Comparative analysis of acute respiratory infections of viral etiology in children under 6 months with and without nirsevimab in the Balearic Islands (2022¿2023 and 2023¿2024) Jordi Reina; Ane Iturbe; Julia Viana-Ramírez; Guida Sbert; Jaume Carrasco; Joaquín Dueñas;

Impact of nirsevimab immunization on RSV infections attended in the pediatric emergency department: First results in a tertiary hospital in Madrid Miguel Ángel Molina Gutiérrez; Begoña de Miguel Lavisier; José Antonio Ruiz Domínguez; María García de Oteyza; Virginia María Velasco Molina; Almudena Gutiérrez Arroyo; María de Ceano-Vivas;

Impact of the passive immunization campaign with nirsevimab in 2023¿24 in Castellón. Final results Eulalia Gregori-García; Juan Carlos Gascó-Laborda; Lledó Lluch-Bacas; Oscar Pérez-Olaso; Iris Gómez-Alfaro; Juan B. Bellido-Blasco;